Abstract
The hallmark clinical signs of age-related macular degeneration (AMD) in its early stages are the presence of drusen and pigmentary change in the macula, which can be present for many years prior to the development of vision-threatening complications. Significant progress has been made in understanding the pathogenic pathways involved in AMD and, as such, novel intervention strategies in the early stages of AMD are currently being developed or trialed.

This publication has 27 references indexed in Scilit: